Abstract
An expert meeting to discuss population pharmacokinetic/pharmacodynamic software was held in Brussels in November 1993 under the auspices of the European Co-operation in Science and Technology (COST), Medicine (B1) programme.
Recently developed statistical methods offer the possibility of gaining integrated information on pharmacokinetics and response from relatively sparse observational data obtained directly in patients who are being treated with the drug under development. These methods can minimize the need to exclude patient groups and also allow analysis of a variety of unbalanced designs that frequently arise in the evaluation of the relationships between dose or concentration on the one hand and efficacy or safety on the other relationships that do not readily lend themselves to other forms of statistical analysis.
The purpose of the Brussels meeting was to evaluate the state of both existing software and software under development, and to specify the needs and wishes of potential users of such software. It was apparent from the meeting that software development for population data analysis is currently a very active area of investigation and that several very good packages are already available, with more in development.
The general consensus of the meeting was that well validated, easy to use software was essential to the implementation of the population approach to drug development.
Article PDF
Avoid common mistakes on your manuscript.
References
Rowland M, Aarons L (eds) (1992) New strategies in drug development and clinical evaluation: the population approach. Commission of the European Communities, Luxembourg
Beal SL, Sheiner LB (1980) The NONMEM system. Am Statistics 34: 118–119
Lindstrom MJ, Bates DM (1990) Nonlinear mixed effects models for repeated measures data. Biometrics 46: 673–687
Mallet A (1986) A maximum likelihood estimation method for random coefficient regression models. Biometrika 73: 645–656
Schumitzky A (1991) Nonparametric EM algorithms for estimating prior distributions. Appl Math Comput 45: 141–157
Wakefield J, Smith AFM, Racine-Poon A, Gelfand A (1994) Bayesian analysis of linear and nonlinear population models using the Gibbs sampler. Applied Statistics 43: 201–221
Author information
Authors and Affiliations
Additional information
Participants: L.Aarons (UK), L.Balant (Switzerland), P.Bechtel (France), A.Boobis (UK), R.Bruno (France), H.Fluhler (Switzerland), R.Gomeni (France), U.Gundert-Remy (Germany), A.Iliadis (France), M.Karlsson (Sweden), P.Kremers (Belgium), L.Lacey (UK), P.Maire (France), A.Mallet (France), G.Pacifici (Italy), K.Pithan (CEC), J.Rodriguez (Spain), M.Rowland (UK), J-L.Steimer (Switzerland), A.Thomson (UK) J. van Bree (Switzerland), S.Vozeh (Switzerland), J.Wakefield (UK), B.Whiting (UK), A.Zipfel (France)
All authors were members of the COST-B1 Working Party on Population Approaches
Rights and permissions
About this article
Cite this article
Aarons, L., Balant, L.P., Mentré, F. et al. Population approaches in drug development. Eur J Clin Pharmacol 46, 389–391 (1994). https://doi.org/10.1007/BF00191898
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00191898